{"title":"原发性眼附件滤泡性淋巴瘤的临床特点和预后:回顾性分析。","authors":"Shohei Nakamura, Shinichi Makita, Akiko Miyagi-Maeshima, Yoshikazu Hori, Haruhi Makino, Hirokazu Sasaki, Daiki Hattori, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Hiroshi Igaki, Shigenobu Suzuki, Koji Izutsu","doi":"10.1007/s12185-025-04029-6","DOIUrl":null,"url":null,"abstract":"<p><p>Extranodal follicular lymphoma (FL) demonstrates unique clinicopathological features and prognostic implications, and the clinical characteristics of ocular adnexal FL are poorly documented. In this study, we retrospectively analyzed histologically confirmed cases of ocular adnexal FL at our institution between 1997 and 2019. Of the 261 patients with lymphoma involving the ocular adnexa, 28 had FL, and staging revealed that 10 had primary ocular adnexal FL. Of these 10 patients, one was excluded because of insufficient treatment information. The median age of the remaining nine patients (six women) was 62 (range: 24-81) years. Lesions were located in the orbit (three patients) or conjunctiva (six patients). Three patients had bilateral conjunctival lesions. Eight patients were initially treated with radiotherapy (including one who received radiotherapy after 1.5 years of observation); the other patient remained untreated for 6.4 years. With a median follow-up period of 7.7 years, three of eight patients who received radiotherapy relapsed (two in the contralateral conjunctiva, one in the subcutaneous tissue of the back), and no in-field relapses occurred. The 5-year progression-free and overall survival rates were 75% and 100%, respectively, without histological transformation. In conclusion, primary ocular adnexal FL has a favorable prognosis after radiotherapy and/or watchful waiting.</p>","PeriodicalId":13992,"journal":{"name":"International Journal of Hematology","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical features and outcomes of primary ocular adnexal follicular lymphoma: a retrospective analysis.\",\"authors\":\"Shohei Nakamura, Shinichi Makita, Akiko Miyagi-Maeshima, Yoshikazu Hori, Haruhi Makino, Hirokazu Sasaki, Daiki Hattori, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Hiroshi Igaki, Shigenobu Suzuki, Koji Izutsu\",\"doi\":\"10.1007/s12185-025-04029-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Extranodal follicular lymphoma (FL) demonstrates unique clinicopathological features and prognostic implications, and the clinical characteristics of ocular adnexal FL are poorly documented. In this study, we retrospectively analyzed histologically confirmed cases of ocular adnexal FL at our institution between 1997 and 2019. Of the 261 patients with lymphoma involving the ocular adnexa, 28 had FL, and staging revealed that 10 had primary ocular adnexal FL. Of these 10 patients, one was excluded because of insufficient treatment information. The median age of the remaining nine patients (six women) was 62 (range: 24-81) years. Lesions were located in the orbit (three patients) or conjunctiva (six patients). Three patients had bilateral conjunctival lesions. Eight patients were initially treated with radiotherapy (including one who received radiotherapy after 1.5 years of observation); the other patient remained untreated for 6.4 years. With a median follow-up period of 7.7 years, three of eight patients who received radiotherapy relapsed (two in the contralateral conjunctiva, one in the subcutaneous tissue of the back), and no in-field relapses occurred. The 5-year progression-free and overall survival rates were 75% and 100%, respectively, without histological transformation. In conclusion, primary ocular adnexal FL has a favorable prognosis after radiotherapy and/or watchful waiting.</p>\",\"PeriodicalId\":13992,\"journal\":{\"name\":\"International Journal of Hematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12185-025-04029-6\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12185-025-04029-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Clinical features and outcomes of primary ocular adnexal follicular lymphoma: a retrospective analysis.
Extranodal follicular lymphoma (FL) demonstrates unique clinicopathological features and prognostic implications, and the clinical characteristics of ocular adnexal FL are poorly documented. In this study, we retrospectively analyzed histologically confirmed cases of ocular adnexal FL at our institution between 1997 and 2019. Of the 261 patients with lymphoma involving the ocular adnexa, 28 had FL, and staging revealed that 10 had primary ocular adnexal FL. Of these 10 patients, one was excluded because of insufficient treatment information. The median age of the remaining nine patients (six women) was 62 (range: 24-81) years. Lesions were located in the orbit (three patients) or conjunctiva (six patients). Three patients had bilateral conjunctival lesions. Eight patients were initially treated with radiotherapy (including one who received radiotherapy after 1.5 years of observation); the other patient remained untreated for 6.4 years. With a median follow-up period of 7.7 years, three of eight patients who received radiotherapy relapsed (two in the contralateral conjunctiva, one in the subcutaneous tissue of the back), and no in-field relapses occurred. The 5-year progression-free and overall survival rates were 75% and 100%, respectively, without histological transformation. In conclusion, primary ocular adnexal FL has a favorable prognosis after radiotherapy and/or watchful waiting.
期刊介绍:
The International Journal of Hematology, the official journal of the Japanese Society of Hematology, has a long history of publishing leading research in hematology. The journal comprises articles that contribute to progress in research not only in basic hematology but also in clinical hematology, aiming to cover all aspects of this field, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. The expanded [Progress in Hematology] section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. Reports on results of clinical trials are also included, thus contributing to the aim of fostering communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.